3.12
0.01 (0.32%)
| Previous Close | 3.11 |
| Open | 3.13 |
| Volume | 28,144,131 |
| Avg. Volume (3M) | 45,046,020 |
| Market Cap | 36,016,345,088 |
| Price / Earnings (Forward) | 49.02 |
| Price / Sales | 0.920 |
| Price / Book | 39.27 |
| 52 Weeks Range | |
| Earnings Date | 20 Mar 2025 |
| TTM Dividend Yield | 0.17% |
| Profit Margin | -0.09% |
| Operating Margin (TTM) | 0.37% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | 9.40% |
| Quarterly Earnings Growth (YOY) | -66.90% |
| Total Debt/Equity (MRQ) | 15.79% |
| Current Ratio (MRQ) | 1.74 |
| Operating Cash Flow (TTM) | -63.74 M |
| Levered Free Cash Flow (TTM) | 453.70 M |
| Return on Assets (TTM) | 0.71% |
| Return on Equity (TTM) | -0.32% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Distribution (AU) | Mixed | Mixed |
| Medical Distribution (Global) | Bearish | Bearish | |
| Stock | SIGMAHEALT FPO [SIG] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.38 |
|
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model. |
|
| Sector | Healthcare |
| Industry | Medical Distribution |
| Investment Style | Large Growth |
| % Held by Insiders | 3.36% |
| % Held by Institutions | 48.64% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |